共 50 条
- [21] The structural basis for complement receptor type 2 (CR2, CD21)-mediated alternative pathway activation of complement: studies with CR2 deletion mutants and vaccinia virus complement-control protein-CR2 chimerasEUROPEAN JOURNAL OF IMMUNOLOGY, 1999, 29 (12) : 3837 - 3844Johnson, AARosengard, AMSkjodt, KAhearn, JMLeslie, RGQ
- [22] Defective B cell ontogeny and immune response in human complement receptor 2 (CR2, CD21) transgenic mice is partially recovered in the absence of C3MOLECULAR IMMUNOLOGY, 2007, 44 (13) : 3434 - 3444Twohig, JasonKulik, LiudmilaHaluszczak, CatherineReuter, JasonRossbach, AndreasBull, MelanieHolers, V. MichaelMarchbank, Kevin J.
- [23] Signaling through the EBV/C3d receptor (CR2, CD21) in human B lymphocytes: Activation of phosphatidylinositol 3-kinase via a CD19-independent pathwayJOURNAL OF IMMUNOLOGY, 1999, 162 (01): : 136 - 143Bouillie, SBarel, MFrade, R
- [24] Biophysical investigations of complement receptor 2 (CR2, CD21) ligand interactions reveal specific amino acid contacts unique to each receptor-ligand pairMOLECULAR IMMUNOLOGY, 2010, 47 (13) : 2261 - 2261Kovacs, James M.Eisenmesser, Elan Z.Hannan, Jonathan P.Holers, V. Michael
- [25] Defective B cell ontogeny and immune response are partially reversed in aging human complement receptor 2 (CR2, CD21) transgenic miceMOLECULAR IMMUNOLOGY, 2007, 44 (1-3) : 200 - 200Kulik, LiudmilaHolers, V. MichaelMarchbank, Kevin J.
- [26] High levels of human complement receptor 2 (CR2, CD21) expression in Cr2-/- mice results in a marked reduction in peripheral B cell numbersMOLECULAR IMMUNOLOGY, 2001, 38 (2-3) : 109 - 109Marchbank, KJGibson, MMorgan, BPHolers, VM
- [27] Human complement receptor 2 (CR2/CD21) as a receptor for DNA: Implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE)MOLECULAR IMMUNOLOGY, 2013, 53 (1-2) : 99 - 110Asokan, RengasamyBanda, Nirmal K.Szakonyi, GerdaChen, Xiaojiang S.Holers, V. Michael
- [28] EXPRESSION OF CR-2 (THE C3DG/EBV RECEPTOR, CD21) ON NORMAL HUMAN PERIPHERAL-BLOOD LYMPHOCYTES-TJOURNAL OF IMMUNOLOGY, 1991, 146 (03): : 865 - 869FISCHER, EDELIBRIAS, CKAZATCHKINE, MD
- [29] MUTAGENESIS OF RESIDUES IN THE REGION OF HUMAN-COMPLEMENT COMPONENT C3 THAT CORRESPONDS TO THE PROPOSED BINDING-SITE FOR COMPLEMENT RECEPTOR 2 (CR-2, CD21) DOES NOT ABOLISH BINDING OF IC3B OR C3DG TO CR-2FASEB JOURNAL, 1994, 8 (05): : A766 - A766DIEFENBACH, RJISENMAN, DE
- [30] An intronic silencer regulates B lymphocyte cell and stage specific expression of the human complement receptor type 2 (CR2,CD21) gene.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 980 - 980Makar, KWPham, CTDehoff, MOConnor, SJacobi, SHolers, VM